What is International Isotopes Operating Cash Flow per Share?
International Isotopes's operating cash flow per share for the
three
months ended in Sep. 2024 was $0.00.
International Isotopes's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -30.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for International Isotopes's Operating Cash Flow per Share or its related term are showing as below:
INIS'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -100 Med: 12.5 Max: 83.2
Current: -30.7
During the past 13 years, International Isotopes's highest 3-Year average Operating Cash Flow per Share Growth Rate was 83.20% per year. The lowest was -100.00% per year. And the median was 12.50% per year.
INIS's 3-Year OCF Growth Rate is ranked worse than 85.41% of 788
companies
in the Drug Manufacturers industry
Industry Median: 6.8
vs INIS: -30.70
International Isotopes Operating Cash Flow per Share Historical Data
The historical data trend for International Isotopes's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
International Isotopes Operating Cash Flow per Share Chart
Competitive Comparison of International Isotopes's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Isotopes's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, International Isotopes's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where International Isotopes's Price-to-Operating-Cash-Flow falls into.
International Isotopes Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
International Isotopes's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Isotopes Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of International Isotopes's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INIS has been successfully added to your 